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ABSTRACT 
Neoscytalidium spp. are ascomycetous fungi consisting of pigmented and 
hyaline varieties both able to cause skin and nail infection. Their color-based 
identification is inaccurate and may compromise the outcome of the studies with 
these fungi. The aim of this study was to genotype 32 isolates morphologically 
identified as N. dimidiatum or N. dimidiatum var. hyalinum by multilocus 
sequence typing (MLST), differentiate the two varieties by their sequence types, 
evaluate their susceptibility to six commercial antifungal drugs [amphotericin B 
(AMB), voriconazole (VOR), terbinafine (TER), 5-flucytosine (5FC), fluconazole 
(FLU), and caspofungin (CAS)], and also to antimicrobial photodynamic 
treatment (APDT) with the phenothiazinium photosensitizers (PS) methylene 
blue (MB), new methylene blue (NMBN), toluidine blue O (TBO) and the 
pentacyclic derivative S137. The efficacy of each PS was determined, initially, 
based on its minimal inhibitory concentration (MIC). Additionally, the APDT 
effects with each PS on the survival of ungerminated and germinated 
arthroconidia of both varieties were evaluated. Seven loci of Neoscytalidium 
spp. were sequenced on MLST revealing eight polymorphic sites and six 
sequence types (ST). All N. dimidiatum var. hyalinum isolates were clustered in 
a single ST. AMB, VOR and TER were the most effective antifungal agents 
against both varieties. The hyaline variety isolates were much less tolerant to 
the azoles than the isolates of the pigmented variety. APDT with S137 showed 
the lowest MIC for all the isolates of both varieties. APDT with all the PS killed 
both ungerminated and germinated arthroconidia of both varieties reducing the 
survival by up to 5 logs. Isolates of the hyaline variety were also less tolerant to 
APDT. APDT with the four PS also increased the plasma membrane 
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permeability of arthroconidia of both varieties but only NMBN and S137 caused 
peroxidation of the membrane lipids. 
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1. Introduction 
Neoscytalidium spp. (formerly Scytalidium) are ascomycetous, 
dematiaceous (producer of melanins or melanin-like pigments), keratinophilic 
and non-dermatophyte fungi [1]. The taxonomy of the genera is still very 
problematic and has been constantly revised [2-4]. These fungal species are 
worldwide distributed in tropical and subtropical regions and are principally 
known as phytopathogens but some species can infect humans via direct 
contact with colonized plants [1]. Neoscytalidium dimidiatum and its albino 
variant N. dimidiatum var. hyalinum, which does not produce melanin, are 
involved in human infections [5]. Traditionally, the fungus has been 
characterized by producing abundant uni- to tricellular dark arthroconidia [6-9] 
which are nonsexual propagules produced by hypha fission [10]. In culture, N. 
dimidiatum shows cottony, fast-growing colonies that become pigmented, 
usually with a brown to gray color [6-7]. There is a great variety in colony color 
among the so called pigmented isolates and the color-based phenotypic 
distinction between the two varieties is not always straightforward. Therefore, it 
is important to establish a more accurate methodology for the identification of 
the isolates and distinction between the two varieties. The accurate 
identification of the two varieties is important to guide clinical management, to 
associate particular genotypes with medically important traits such as virulence 
and antifungal drug susceptibility and to perform epidemiological studies [2,11]. 
Unlike N. dimidiatum, which is commonly isolated from plants and soil samples, 
the albino variety has been isolated exclusively from human infections [2, 12-
13]. The two varieties have also different geographical distributions. N. 
dimidiatum was isolated from environmental samples and patients in Central 
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Africa, Asia and the Indian Ocean region, whereas the hyaline variety was 
exclusively isolated from patients in South America, West Africa and the West 
Indies [5, 14-15]. The hyaline variety is responsible for chronic infections in 
toenail, interdigital spaces, soles and palms [1, 2, 5, 16-19] which are clinically 
similar to N. dimidiatum infections and indistinguishable from dermatophytosis 
[1-2, 16-17]. The dematiaceus variety is responsible not only for superficial 
infection as N. dimidiatum var. hyalinum, but also for invasive and deeper 
infection such as subcutaneous infections [20-21], sinusitis [22-23], 
endophtalmitis [24], cerebral pheohyphomycosis [25], pneumonia [8,26], and 
disseminated infections [27-29]. As the number of mycoses caused by both 
varieties is increasing [7,9,30] there is a renewed interest in the study of these 
fungi. 
Only a few studies have reported the comparison of the antifungal 
susceptibility of both N. dimidiatum and N. dimidiatum var. hyalinum [2,16-
17,31]. Amphotericin B, voriconazole and terbinafine are the only antifungals 
that have shown in vitro activity against both varieties [2,16-17,32-33]. However, 
unlike infections caused by dermatophytes, the treatment of mycoses caused 
by Neoscytalidium spp. with conventional antifungal drugs results in poor 
outcomes due to antifungal resistance [1,5,19,34]. Therefore, due to the 
limitation of current therapeutic options, the development of new approaches to 
treat mycosis caused by Neoscytalidium spp. is necessary. 
Antimicrobial photodynamic therapy (APDT) has been described as an 
effective alternative to conventional fungicides to treat localized mycoses [35]. 
The photodynamic process results from the combination of three elements: light 
of an appropriate wavelength, oxygen, and a photosensitizer (PS), which 
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accumulates preferentially in the target microorganism [36]. As a consequence 
of the photodynamic process, several reactive oxygen species (ROS) are 
produced and they subsequently kill the microbial cells without significant 
damage to the host [36]. More importantly, given the multiple cellular targets of 
ROS, the selection of tolerant microorganisms is less probable in APDT than in 
treatments with conventional antifungal drugs [35]. Among the PS examined for 
antifungal use, the phenothiazinium derivatives methylene blue (MB), new 
methylene blue (NMBN) and toluidine blue O (TBO) are particularly attractive, 
mainly due to their low toxicities to mammals and other clinical uses [35,37]. 
Novel derivatives, such as the pentacyclic S137, and derivatives with basic side 
chains, more effective than the lead compound MB are still being synthesized 
[38-39]. Previous studies have reported that APDT with phenothiazinium 
derivatives kills different fungal structures, such as microconidia of different 
species including the dermatophyte Trychophyton spp. [40, 43] and the non-
dermatophyte Fusarium spp. [44] and conidia of Exophiala spp. [42], 
Colletotrichum spp. [53], Metarhizium anisoplia, and Aspergillus nidulans [41]. 
As far as we know there is no data regarding the effect of APDT with 
phenothiazinium derivatives on arthroconidia of any species. 
The aims of this study were: (1) to determine if multilocus sequence 
typing allows the distinction between the isolates of N. dimidiatum and N. 
dimidiatum var. hyalinum; (2) to investigate the genotype distribution of Brazilian 
clinical isolates of the two varieties; (3) to evaluate the in vitro susceptibility of 
the arthroconidia of the different sequence types to conventional antifungal 
drugs and to APDT with phenothiazinium photosensitizers, and (4) to compare 
the susceptibilities of the two varieties to antifungals and APDT. 
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2. Material and Methods 
2.1. Fungal clinical isolates 
 
A total of 30 isolates identified by their morphological characteristics as 
N. dimidiatum or N. dimidiatum var. hyalinum was obtained from the Serviço de 
Análises Clínicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto 
(FCFRP), University of São Paulo (USP). Fungi were isolated from skin and 
toenail infections of patients residing in Ribeirão Preto (São Paulo, Brazil) and 
neighboring cities from 2004 to 2014 (Table 1). The American Type Culture 
Collection (ATCC) strains, ATCC®22190™ (previously identified as N. 
dimidiatum) and ATCC®38907™ (previously identified as N. dimidiatum var. 
hyalinum) were also included in the study (Table S1). This study was approved 
by the Research Ethics Committee of the Faculdade de Ciências 
Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, 
SP, Brazil. 
 
2.2. Fungal isolation and production of arthroconidia and mycelia 
 
Fungal strains were isolated from scrapings of foot and/or toenail placed 
on both sabouraud dextrose agar (SDA) (Acumedia , Michigan, USA) with 
chloramphenicol (50 mg L-1) and SDA with chloramphenicol (50 mg L-1) and 
cycloheximide (400 mg L-1). Plates were incubated at 28ºC for 4 days. 
The arthroconidia were produced by culturing the fungi on SDA at 28ºC 
for 4 days. Arthroconidia were suspended in sterile 0.01% (v/v) Tween 80 
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solution (Sigma-Aldrich Inc., St. Louis, MO, USA) and filtered through sterile 
glass wool (Sigma-Aldrich). The filtered arthroconidia were pelleted by 
centrifugation (3000 g) and resuspended in PBS, pH 7.4. The concentrations of 
arthroconidia were determined with hemocytometer. 
Fungal mycelia were obtained by culturing 1 × 107 arthroconidia in 50 mL 
of potato dextrose broth (PDB) at 28ºC for 24 h and 180 rpm (Ecotron, Infors 
HT, Switzerland). Subsequently, fungal mycelia were filtered through Miracloth 
(Calbiochem, La Jolla, CA) and frozen in liquid nitrogen. 
 
2.3. DNA extraction, multilocus sequence typing and phylogenetic analysis 
 
The genomic DNA (gDNA) was extracted from fungal mycelia ground 
under liquid nitrogen using a mortar and pestle. The gDNA was extracted with 
extraction buffer (200 mM Tris-HCl pH 8.5, 250 mM NaCl, 25 mM EDTA, 0.5% 
w/v SDS) and phenol-chloroform (1:1). After centrifugation, the gDNA was 
precipitated with isopropanol and resuspended with RNase-free water 
(Promega, Madison, WI). 
Multilocus sequence typing (MLST) was performed by PCR, DNA 
sequencing and nucleotide sequence analysis. All PCR reactions were 
performed with Phusion® High Fidelity DNA Polymerase (Thermo Fisher 
scientific Inc., Waltham, MA, USA) according to the manufacturer’s instructions. 
The following seven loci were chosen for MLST: the internal transcribed spacer 
regions 1 (ITS1) and 2 (ITS2) of the 28S rRNA; the chitin synthase (CHS); the 
histone H3 (HH3); the glyceraldehyde-3-phosphate dehydrogenase (GPD); the 
β-tubulin (TUB), and the elongation factor 1α (EF1). The primers for ITS1 and 
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ITS2 amplification were designed according to White et al. [45], and for the 
amplifications of the other sequences the following primers were designed 
based on published sequences in GenBank [46]: CHS (CHS_f 5’-
GTGTGCGTTGTCAGCGAC-3’, CHS_r 5’-TCCTTCAAACAGAAAAGCATC-3’), 
TUB (TUB_f 5’-CAGCTGAACTCTGACCTGC- 3’, TUB_r 5’-
AGCAGTGAACTGGTCACC-3’), HH3 (HH3_f 5’-CGCTGCGTCGCTGTTGC-3’, 
HH3_r 5’-CTACAATACCGTTAGTAATGC-3’), GPD (GPD_f 5’-
AGCTGACCCACGCCACCA-3’, GPD_r 5’-ACCGTCGACGGTCTTCTG-3’), EF-
1 (EF1_f 5’-TCGACAAGCGTACCATCGAG-3’, EF1_r 5’-
AGCCTTGAGCTTGTCAAGGA-3’). 
DNA sequences were determined with the ABI3730 DNA Analyzer 
(Applied Biosystems, Foster City, CA), analyzed with ChromasPro® software 
(ChromasPro 1.7.6, Technelysium Pty Ltd, Tewantin QLD, Australia) and 
compared with the DNA sequences database of the Basic Local Alignment 
Search Tool (BLAST) [47]. The MLST analysis was performed by the multiple 
DNA alignment method using the ‘Molecular Evolutionary Genetics Analysis - 
MEGA’ 6.0 software [48]. The GenBank accession numbers of each sequence 
are listed in supplementary Table S1. The combination of alleles for the different 
loci defined the sequence type (ST) of each clinical isolate. Phylogenetic 
analysis was conducted by inferring the evolutionary history using the 
unweighted-pair group method with arithmetic averages and arithmetic mean 
(UPGMA) [49]. The robustness of the dendrogram was evaluated from 1000 
bootstrap replications. The evolutionary distances were computed using the p-
distance method [50-51]. The analyses were performed using MEGA 6.0 
software [48]. 
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2.4. In vitro antifungal susceptibility test 
 
Data regarding the antifungal susceptibility of the two varieties are 
scarce, particularly of the Brazilian isolates. As this information is important both 
for therapeutic and epidemiological purposes, the susceptibilities of all the 
clinical isolates to seven currently-used antifungal drugs were determined. The 
susceptibility tests were conducted according to the Clinical Laboratory 
Standards Institute (CLSI) reference method for broth dilution antifungal 
susceptibility testing of filamentous fungi (CLSI document M38-A2) [52]. The 
antifungal drugs amphotericin B (AMB), ketoconazole (KET), fluconazole (FLU), 
voriconazole (VOR), 5-flucytosine (5FC), and terbinafine (TER) were purchased 
from Sigma-Aldrich. Caspofungin (CAS) was purchased from Merck Sharp & 
Dohme Limited (Kenilworth, NJ, USA). The final concentrations were 0.03 to 32 
μg mL-1 for AMB, 0.03 to 16 μg mL-1 for VOR and TER, 0.125 to 64 μg mL-1 for 
CAS, and 0.25 to 128 μg mL-1 for 5FC, KET and FLU. The experiments were 
performed in 96-well, flat-bottomed microtitre plates (TPP, Switzerland) with 
RPMI 1614 culture medium (Gibco, Invitrogen Corporation, NY, USA) buffered 
with 0.165 M 3-(N-morpholino)propanesulfonic acid (MOPS), pH 7.0, antifungal 
drugs and 2 × 104 arthroconidia mL-1. After 48 h of incubation at 28ºC, minimal 
inhibitory concentrations (MIC) were determined visually by comparison with the 
growth in the control well (culture medium and 2 × 104 athroconidia mL-1). The 
MIC endpoint was defined as the minimal concentration of the drug capable of 
inhibiting 100% of fungal growth compared with the growth control for 
amphotericin B and 5-flucytosine and to inhibit 90% for azoles, terbinafine and 
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caspofungin. Geometric means and MIC ranges were calculated for each 
species and antifungal drug. The standard quality control strains of the 
experiment were Aspergillus flavus (ATCC®204304™) and Candida krusei 
(ATCC®6258). The tests were repeated three times. 
 
2.5. Phenothiazinium photosensitizers and visible light sources 
 
The phenothiazinium photosensitizers methylene blue (MB), new 
methylene blue N zinc chloride double salt (NMBN) and toluidine blue O (TBO) 
were purchased from Sigma-Aldrich. The novel pentacyclic phenothiazinium 
photosensitizer S137 was synthesized as previously described [38]. The 
chemical structures of all the PS are show in supplementary Figure S1. Stock 
solutions of all PS were prepared with phosphate buffered saline (PBS), pH 7.4 
and stored as previously described [40]. 
Light was provided by an array of 96 light-emitting diodes (LED) with 
emission peak at 631 nm (LED96). The array was made in-house using the 
Cree®5-mm Round LED (model # LC503UHR1-1 5Q-Q, CREE Inc., Durham, 
NC, USA). The integrated irradiance in the visible spectrum (400 to 700 nm) 
was 13.89 mW cm-2. Light measurement was performed by using a cosine-
corrected irradiance probe (CC-3-UV, Ocean Optics, USA) screwed onto the 
end of an optical fiber coupled to an USB4000 spectroradiometer (Ocean 
Optics, Dunedin, FL, USA). Light was measured inside the well, at the sample 
level, to reduce interference of the plastic plate. The emission spectra of the 
LED array and the absorption spectra of the PS are presented in supplementary 
Figure S2. 
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2.6. Evaluation of APDT efficacies on arthroconidia based on the PS minimal 
inhibitory concentration 
 
Minimal inhibitory concentration (MIC)-based experiments were 
conducted as previously described [39,40,53] to determine the best conditions 
for APDT of arthroconidia of N. dimidiatum and N. dimidiatum var. hyalinum. 
Eleven isolates, three of the sequence type 1, one of the sequence type 2, one 
of the sequence type 3, two of the sequence type 4, three of the sequence type 
5 and one of the sequence type 6 were evaluated. Experiments were performed 
in 96-well microtiter plates (TPP, Switzerland). Fifty µL of the arthroconidia 
suspension (4 × 104 athroconidia mL-1) and 50 µL of the PS solution were 
added to each well. Final concentrations of MB, NMBN and TBO were 0, 1, 2.5, 
5, 10, 12.5, 25, 50, 75, 100, and 200 μM and the final concentrations of S137 
were 0, 0.5, 1, 2.5, 5, 10, 12.5, 20, 25, 30 and 40 µM. Plates were incubated in 
the dark for 30 min at 28°C and exposed to light fluences of 3, 6, and 11 J cm-2 
or kept in the dark (dark controls). After the exposures, 100 µL of two-fold 
concentrate RPMI 1614 culture medium buffered with 0.165 M MOPS pH7.0 
were added to each well and plates were incubated at 28°C. Fungal growth in 
each well was evaluated after 7 days by visual inspection when the MICs were 
determined. MIC was considered the minimal concentration of the PS for each 
fluences, in which total growth inhibition was achieved. Three independent 
experiments  were performed in triplicate. 
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2.7. Effect of APDT with MB, TBO, NMBN or S137 on the survival of 
ungerminated and germinated arthroconidia 
 
Based on the previous MIC experiments, the best conditions were 
established and the effect of APDT on the survival of ungerminated 
arthroconidia was determined as previously described [37,40]. Two selected 
isolates of N. dimidiatum (LMC 302.01 and 301.01) and one of N. dimidiatum 
var. hyalinum (LMC 3313.01) were evaluated. Experiments were performed in a 
96 microtiter plate (TPP, Switzerland). Fifty µL of the arthroconidia suspension 
and 50 µL of the PS solution (MB, NMBN, TBO, or S137) were added to each 
well. The final concentration of the arthroconidia in the mixture was 2 × 107 
artroconidia mL-1 and the final concentrations of MB, NMBN, TBO and S137 
were 200, 200, 200, and 25 μM, respectively, for N. dimidiatum; and 25, 25, 10, 
and 10 μM, respectively, for N. dimidiatum var. hyalinum. Plates were 
maintained in the dark for 30 min at 28°C and exposed to light fluences of 3, 6, 
and 11 J cm-2 or kept in the dark. After exposure, arthroconidial suspensions 
were removed, serially diluted 10-fold in PBS, and 50 μL of each dilution was 
spread onto potato dextrose agar (Acumedia) supplemented with 0.08 g L-1 
deoxycholic acid sodium salt (Fluka, Italy). Plates were incubated in the dark at 
28°C and colony forming units (CFU) were counted daily at 8× magnification for 
up to 4 days. Three replicate dishes were prepared for each treatment in each 
experiment and three independent experiments were performed. The effect of 
the different treatments was calculated as previously described [53]. 
The effect of APDT was further evaluated on germinated arthroconidia. 
For this, the arthroconidia were previously germinated in RPMI 1614 culture 
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medium buffered with 0.165 M MOPS pH7.0 at 28ºC for 4 h. APDT of germlings 
was carried out exactly as ungerminated arthroconidia. 
 
2.8. Evaluation of APDT effect on plasma membrane permeability 
 
The permeability of the arthroconidial plasma membrane after APDT was 
evaluated by measuring the incorporation of propidium iodide (PI) by 
arthroconidia. PI is a positively-charged fluorescent nucleic acid dye which only 
penetrates cells with severe membrane damage [44,54]. Experiments were 
performed in a 24-well flat bottomed microtiter plate (TPP, Switzerland). 
Ungerminated arthroconidia were exposed to APDT as previously described. 
After APDT, arthroconidia were transferred from each well to 1.5-mL tubes, 
washed once with PBS and PI solution was added to a final concentration of 10 
μg mL-1 immediately before flow cytometric analysis. The single-cell light 
scattering and fluorescence measurements were performed using a 
FACSCanto flow cytometer (Becton Dickinson, Sunnyvale, CA, USA). Ten 
thousand events were analyzed by FACSDiva software (BD, San Jose, CA, 
USA). The percentage of cells stained with PI after each treatment was 
determined. Three independent experiments were performed. The results were 
compared with the ‘gold-standard’ determination of viable cells (arthroconidia 
survival fraction) by CFU-based experiments. Arthroconidia not treated with PS 
neither exposed to light were used as control of conidial viability and 
arthroconidia treated with 70% ethanol for 15 min were used as positive control 
(death control). 
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2.9. Effects of APDT on lipid peroxidation 
 
The evaluation of lipid peroxidation in arthroconidia after APDT was 
determined by measuring the production of malonildialdehyde (MDA) using the 
Lipid Peroxidation (MDA) Assay Kit (Sigma-Aldrich, Inc. - St. Louis, MO, USA) 
following the manufacturer’s protocol with slight modification. MDA is a product 
of the oxidation of polyunsaturated lipids by reactive oxygen species (ROS). 
Arthroconidia were exposed to APDT as previously described. After treatments, 
arthroconidia were recovered from each well, transferred to a 1.5-mL microtube, 
centrifuged for 5 min at 5000 g and lysed with MDA lysis buffer (300 μL) and 
BHT 100× (3 μL). The insoluble material was removed by centrifugation for 10 
min at 13000 g. Two hundred microliters of the supernatant from each sample 
were transferred to a new 1.5-mL microtube and incubated at 95ºC for 1 h with 
600 μL of TBA solution. Samples were cooled in ice bath for 10 min and 200 μL 
of each sample were transferred to a 96-well flat-bottomed microtitre plate. 
Absorbances at 532 nm were determined using a Spectramax® Paradigm® 
Multi-Mode Detection Platform (Molecular Device LLC, Sunnyvale, CA). A 
standard curve was used to calculate MDA concentration in each sample. Three 
independent experiments were performed in triplicate. The results were also 
compared with arthroconidial survival determined by CFU counting. 
 
2.10. Statistical analysis 
 
Treatment comparisons were performed using one-way analysis of 
variance (one-way ANOVA) followed by Tukey’s post-test and P values of < 
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0.05 were considered significant. All computations were performed using 
GraphPad Prism Software (v 5.0 GraphPad Software, La Jolla, CA, USA). 
 
3. Results 
3.1 Multilocus sequence typing and phylogenetic analysis 
 
MLST was performed by the sequencing of ITS1 and ITS2 regions of the 
rDNA and the conserved genes CHS, HH3, GPD, TUB and EF1 in order to 
determine the genotypes of a collection of 24 N. dimidiatum and 6 N. 
dimidiatum var. hyalinum strains isolated from skin and toenail infections. Two 
ATCC strains were also genotyped (Table S1). The nucleotides sequence of 
ITS2 region and conserved genes CHS and GPD did not show polymorphic 
sites among the clinical isolates and ATCC strains. However, eight polymorphic 
sites were found in the sequence of ITS1 region and EF1, TUB and HH3 genes 
(Table 1). ITS1 has a transition from guanine to adenine at 105 bp of the 
sequenced region (Table 1). The nucleotide sequence of EF1 has shown four 
polymorphic sites throughout the intron sequence. The transitions from thymine 
to cytosine, cytosine to thymine, adenine to guanine and the transversion from 
adenine to cytosine were found at sites 103, 188, 198 and 214 bp, respectively. 
Two polymorphic sites were found in the TUB gene. The first site is the 
transition from thymine to cytosine at position 312 bp. The codon CTT (cytosine 
thymine thymine) encodes the amino acid leucine while the codon CCT 
(cytosine cytosine thymine) encodes the amino acid proline. The second 
polymorphic site has shown a transition from cytosine to thymine at position 319 
bp which is a silent mutation since both codons encode serine. The nucleotide 
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sequence of HH3 has shown a polymorphic site at 265 bp with a transition from 
adenine to guanine, which represents a silent mutation, in which both codons 
encode glutamate (Table 1). 
The combination of the eight polymorphic sites found in ITS1 region of 
the rDNA and in the sequences of the EF1, TUB, and HH3 genes determined 
six sequences types (STs) (Table 1). Most of the N. dimidiatum clinical isolates 
(64%) were clustered in ST1 and 5.2%, 2.6% and 12.8% of the isolates were 
clustered in ST2, ST3 and ST4, respectively. The N. dimidiatum var. hyalinum 
represents 15.4% of the clinical isolates and all of them together with the isolate 
ATCC®38907™ (N. dimidiatum var. hyalinum) were clustered in ST5. The only 
member of ST6 was the isolate ATCC®22190™ (N. dimidiatum). 
The evolutionary history of N. dimidiatum and N. dimidiatum var. 
hyalinum isolates using the 2075 bp originated from the concatenation of the 
seven loci dataset (ITS1, ITS2, EF1, TUB, HH3, CHS and GPD), generated the 
UPGMA dendrogram based on p-distance (Fig. 1). The bootstrap values were 
registered in the nodes of the UPGMA phylogenetic tree. The main set of the 
isolates could be differentiated into two subgroups (A and B), with strong 
bootstrap support. Significant association was found between the subgroups, 
regarding the presence or absence of the dark-brown pigment. All the isolates 
of subgroup A produce pigments and their arthroconidia and hyphae are 
pigmented while none of the isolates of the subgroup B produces pigments and 
their arthroconidia and hyphae are hyaline. The result shows that the isolates of 
the two varieties can be accurately differentiated by the multilocus sequence 
typing. 
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3.2 In vitro antifungal susceptibility test 
 
The in vitro activities of seven antifungal drugs were tested against 24 N. 
dimidiatum and 6 N. dimidiatum var. hyalinum clinical strains isolated from skin 
and toenail infections, and two ATCC strains. The antifungal drugs which 
demonstrated lower minimal inhibitory concentrations (MICs) against all isolates 
(STs 1 to 6) were AMB (MIC range 0.03 - 0.5 μg mL-1 and Geometric Mean 
(GM) MIC 0.126 μg mL-1), TER (0.125 - 4 μg mL-1 and 0.75 μg mL-1) and VOR 
(0.125 - 4 μg mL-1 and 1.68 μg mL-1). 5FC (1 - 32 μg mL-1 and 12.95 μg mL-1) 
and CAS (8 - 64 μg mL-1 and 27.02 μg mL-1) exhibited lower MICs in 
comparison with KET (0.5 - >128 μg mL-1 and 58.81 μg mL-1) and FLU (8 - >128 
μg mL-1 and 95.63 μg mL-1) (Table 2). Compared with N. dimidiatum isolates 
(ST1 to 4), N. dimidiatum var. hyalinum isolates (ST5) were more sensitive to 
VOR (0.125 - 0.5 μg mL-1 and 0.27 μg mL-1), KET (0.5 - 16 μg mL-1 and 3.62 μg 
mL-1) and FLU (8 - 64 μg mL-1 and 39 μg mL-1 - P < 0.05). ST6 showed lower 
MIC than STs 1 to 4 for FLU (32 - 64 μg mL-1 and 45.25 μg mL-1) and KET (1 μg 
mL-1 and 1 μg mL-1 – P < 0.05) (Table 2). 
 
3.3. Evaluation of APDT efficacies on arthroconidia based on PS minimal 
inhibitory concentration 
Exposure only to red light did not inhibit the growth of any of the isolates. 
In the dark, treatments with MB, NMBN and TBO in concentrations up to 200 
µM did not inhibit the growth of any of the isolates, while S137 at concentrations 
> 50 μM inhibited the growth of all of them (Table 3). The MICs of each 
photosensitizer (MB, NMBN, TBO and S137) at each fluence for the 11 selected 
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isolates of N. dimidiatum and N. dimidiatum var. hyalinum are shown in Table 5. 
Based on the PS MIC, S137 was the most effective PS followed by NMBN. MB 
and TBO were less effective. Concentrations of S137 > 25 µM inhibited the 
growth of all the isolates at all the fluences, and most of the isolates were 
inhibited by concentrations > 10 µM. MIC-based experiments also showed that 
arthroconidia of the N. dimidiatum var. hyalinum isolates (ST 5) are more 
susceptible to APDT than the pigmented arthroconidia of the N. dimidiatum (ST 
1, 2, 3 and 4) regardless the photosensitizer used (Table 5). 
 
3.4. Effect of APDT with MB, TBO, NMBN or S137 on the survival of 
ungerminated and germinated arthroconidia 
 
The criteria used to select the isolates used in this experiment were the 
MICs for the different PS and colony color. The MICs of the isolates of the ST1, 
2, 3 and 4 were similar but they differ from those of the ST5. Regarding the 
colony color, N. dimidiatum isolates have shown different pattern (i.e. brown 
and gray), while none of the isolates of N. dimidiatum var. hyalinum produced 
pigments (ST5) (Fig. 2). Thus, the effects of APDT on the survival of 
urgeminated arthroconidia was evaluated on two selected isolates of N. 
dimidiatum (LMC 302.01 - brown and 303.01 - gray), which belong to ST1, and 
one isolate of N. dimidiatum var. hyalinum (LMC 313.01 - hyaline), which 
belongs to ST5 (Fig. 2). The concentrations of the different PS were selected 
based on the results of the MIC experiments (Table 5). Thus, PS concentrations 
used for N. dimidiatum were 200 μM for MB, NMBN and TBO, and 25 μM for 
S137. PS concentrations used for N. dimidiatum var. hyalinum were 25 μM for 
20 
 
MB and NMBN, and 10 μM for TBO and S137. Exposure only to light and 
treatments with MB, NMBN or TBO in the dark did not kill the conidia of any 
isolate. Treatment with S137 in the dark killed 58.3%, 39.8% and 0% of the 
arthroconidia of N. dimidiatum (LMC302.01), N. dimidiatum (LMC303.01) and N. 
dimidiatum var. hyalinum (LMC313.01), respectively. APDT with MB and TBO 
at 3 J cm-2 reduced the survival of N. dimidiatum (both isolates) and N. 
dimidiatum var. hyalinum arthroconidia by 1 log and 4 logs, respectively. At 6 J 
cm-2 reductions were 3 logs and 5 logs, and at 11 J cm-2 reductions were 4.5 
logs and 5 logs, respectively (P < 0.05 for all treatment comparisons). APDT 
with NMBN at 3 J cm-2 reduced the survival of N. dimidiatum (LMC302.01 and 
LMC303.01) and N. dimidiatum var. hyalinum (LMC313.01) arthroconidia by 3 
logs, 3 logs and 5 logs, respectively. At 6 and 11 J cm-2, reductions in the 
survival were 5 logs, 4 logs and 5 logs for the three isolates, respectively (P < 
0.05 for all treatment comparisons) (Fig. 3). APDT with S137 at 3 J cm-2 
reduced the survival of N. dimidiatum (LMC302.01 and LMC303.01) and N. 
dimidiatum var. hyalinum (LMC313.01) by 3.5 logs, 2.5 logs and 2 logs, 
respectively. At 6 J cm-2, reductions were 5 logs, 2.5 logs and 2.5 logs, and at 
11 J cm-2 the reductions were 5 logs, 5 logs and 3.5 logs (P < 0.05 for all 
treatment comparisons) (Fig. 3). 
In addition, APDT with MB, NMBN, TBO and S137 at a fluence of 6 J cm-
2 was carried out with 4-h germinated arthroconidia of N. dimidiatum 
(LMC302.01 and LMC303.01) and N. dimidiatum var. hyalinum (LMC313.01). 
Results were very similar to those observed with ungerminated arthroconidia 
(Supplementary Fig. S3). Thus, APDT with MB, NMBN, TBO and S137 are able 
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to kill both ungerminated and germinated arthroconidia of N. dimidiatum and N. 
dimidiatum var. hyalinum equally well. 
 
3.5. Effect of APDT on the permeability of the arthroconidia plasma membrane 
 
The effects of APDT with the four PS on the arthroconidial survival and 
plasma membrane permeability of the three selected isolates are shown in Fig. 
4. Ungerminated arthroconidia were treated with MB, NMBN, TBO or S137 and 
exposed to light or kept in the dark. PS concentrations used for the two N. 
dimidiatum isolates (LMC302.01 and 303.01) were 200 μM for MB, NMBN and 
TBO, and 25 μM for S137, and concentrations used for the N. dimidiatum var. 
hyalinum isolate (LMC313.01) were 25 μM for MB and NMBN, and 10 μM for 
TBO and S137. After APDT, cells were treated with PI, which only penetrates 
cells with damage in the plasma membrane. Therefore, the higher the 
percentage of arthroconidia stained with PI, the greater the damage caused by 
APDT on the membrane. Exposure only to light did not kill arthroconidia or 
damage their plasma membrane. In the dark, none of the four PS killed the 
arthroconidia, but all of them caused some damage to the plasma membrane. 
The extent of the damage varied depending on the PS and isolate. Despite the 
lower concentration used, S137 caused more damage to the plasma membrane 
of the three isolates as assessed by PI incorporation. The results also showed 
that PI incorporation by arthroconidia does not always mean that the stained 
arthroconidia are dead. For example, treatment with S137 in the dark resulted in 
PI incorporation by virtually all the arthroconidia, but they were still viable. APDT 
with all the PS killed the arthroconidia of the three isolates and also damaged 
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their plasma membranes. PI incorporation was close to 100% after all 
treatments (PS and fluences) (Fig. 4). 
After APDT, an inverse correlation was observed between the 
arthroconidia survival and the percentage of conidia stained with PI (Fig. 4). 
 
3.6. Effects of APDT on lipids peroxidation 
 
Lipid peroxidation was evaluated by the cellular quantification of 
malondialdehyde (MDA). The effects of APDT with MB, NMBN, TBO and S137 
on arthroconidial survival and lipid peroxidation are show in Fig. 5. Exposure 
only to light or treatments only with the PS did not kill the arthroconidia or result 
in lipid peroxidation. APDT with NMBN or S137 but not with MB or TBO resulted 
in the oxidation of the lipids in arthroconidia of the three fungal isolates (Fig. 5). 
 
4. Discussion 
The accurate identification of the isolates of the two N. dimidiatum 
varieties is important not only to guide the therapy, since the varieties present 
different profiles of susceptibility to antifungal drugs, but also to allow 
epidemiological and biogeography studies. To date, few studies regarding the 
molecular distinction between the two varieties have been reported and their 
results varied. Chromosomal DNA of both N. dimidiatum and N. dimidiatum var. 
hyalinum has similar percentages of guanine and cytosine [55]. Amplified 
ribosomal DNA restriction analysis conducted with isolates from North America, 
Europe and North Africa showed that N. dimidiatum is identical to N. dimidiatum 
var. hyalinum [12]. PCR-restriction fragment length polymorphism ribotyping 
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showed an identical sequence for the 18S ribosomal DNA gene of both N. 
dimidiatum and N. dimidiatum var. hyalinum [15]. More specific molecular 
methods, such as the sequencing of the 18S subunit of ribosomal RNA 
performed with isolates from France, North America and North Africa, identified 
nucleotide polymorphism between N. dimidiatum var. hyalinum and N. 
dimidiatum isolates. Additionally, an intronic insertion was observed exclusively 
in N. dimidiatum isolates [13]. The genotyping of N. dimidiatum and N. 
dimidiatum var. hyalinum by the sequencing of four loci (the tubulin and the 
chitin synthase genes and the internal transcribed spacer region and D1/D2 
domain of the 28S rRNA gene) revealed five sequence types (ST) [2]. In our 
study, the genotyping included the sequence analysis of seven loci of 24 N. 
dimidiatum and 6 N. dimidiatum var. hyalinum clinical isolates. Eight 
polymorphic sites have been detected and six ST were determined. 
Interestingly, all the clinical isolates of N. dimidiatum var. hyalinum evaluated in 
the present study and the hyaline ATCC®38907™ isolate clustered together in 
the same sequence type (ST5). The polymorphic sites in ITS1 and TUB allow 
differentiation of the ST5 isolates from the other ST (ST1 to 4 and ST6). Some 
of these polymorphic sites were previously described in N. dimidiatum and N. 
dimidiatum var. hyalinum strains isolated from different sources in Brazil, Egypt, 
USA, Mali and the United Kingdom [2]. Therefore, our results showed that the 
two varieties can be accurately differentiated based on the multilocus 
polymorphism analysis. Also, the genetic difference between the two varieties 
may be higher than it is generally assumed, involving other loci than those 
responsible for pigments biosynthesis. The extent of this difference will be only 
known when several isolates of the two varieties have their genomes 
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sequenced. Thus, for now, differences observed between the two varieties, 
including their susceptibilities to antifungals and to APDT, should not be 
attributed only to the difference in pigmentation. 
The reference microdilution methodologies for in vitro antifungal 
susceptibility testing have not been standardized for Neoscytalidium spp. 
[4,7,34]. Thus, results of the in vitro susceptibility testing with these fungi should 
be interpreted very carefully. AMB, VOR and TER are ranked as the antifungal 
agents with the highest in vitro antifungal activity against N. dimidiatum and the 
hyaline variety [2,16-17,32-33]. In accordance with these data, we found that 
the isolates of N. dimidiatum (ST 1 to 4) and N. dimidiatum var. hyalinum (ST 5) 
were more susceptible to AMB, VOR and TER than to the other antifungal 
agents tested. Additionally, our results clearly showed that the isolates of the 
hyaline variety are much less tolerant to the azole antifungal drugs FLU, VOR 
and KET than the isolates of the pigmented variety. A previous study showed 
that isolates of N. dimidiatum var. hyalinum from Brazil and France were less 
tolerant to VOR than isolates of the pigmented N. dimidiatum [2, 17]. 
Antimicrobial photodynamic therapy with phenothiazinium PS has been 
shown to be a potential alternative to conventional antifungal agents for the 
treatment of mycoses. The use of MB and TBO in the photodynamic treatment 
of onychomycosis was recently reported. Local application of PS (MB and TBO) 
and illumination of infected nails produced a response in 53 out of 62 patients, 
without any collateral effect, and 28 patients showed complete clearance [56]. 
APDT with methyl-aminolevulinate was successfully used to cure a woman with 
onychomycosis of the toes caused by N. dimidiatum [57]. In the present study, 
we demonstrated the in vitro efficacy of APDT with the phenothiazinium PS MB, 
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NMBN, TBO and S137 both on urgerminated and germinated arthroconidia of 
the dematiaceous fungus N. dimidiatum and the hyaline variety N. dimidiatum 
var. hyalinum. The ability to kill ungerminated conidia is a positive aspect of 
APDT, since conidial tolerance to currently-used antifungal agents is frequently 
pointed out as one of the causes of therapeutic failure and recurrence of the 
infections [58-60]. Arthroconidia of N. dimidiatum isolates were more tolerant to 
APDT with all the four phenothiazinium PS than the hyaline isolates (see Table 
5). The protective effect of melanins and melanin-like pigments against 
conventional antifungal drugs [61-63] and also to APDT [64-67] was observed 
previously both in conidia and in vegetative yeast cells. Pigmented conidia of 
Penicillium and Metarhizium are much more resistant to APDT with different PS 
than the colorless mutants [65-66]. In yeasts, Cryptococcus neoformans 
melanized cells are more resistant to APDT than the nonmelanized cells 
[64,67]. Unfortunately the mechanisms responsible for increasing resistance 
due the presence of pigments appear to be diverse and are not yet fully 
understood. Interestingly, arthroconidia of N. dimidiatum are intrinsically much 
more resistant to APDT with the phenothiazinium PS than conidia of other 
previously studied species, such as Colletotrichum acutatum, C. gloesporioides 
[53], Aspergillus nidulans [41], Fusarium oxysporium, F. moniliforme and F. 
solani [44]. This is not surprising, since the different types of fungal asexual 
propagules (i.e. conidia, microconidia and arthroconidia) are very different in 
relation to their ontogeny, dimensions, morphology, physiology, and physical 
properties and chemical composition [10]. Among the tested photosensitizers, 
the pentacyclic derivative S137 was the most effective. The MICs of S137 were 
lower than the MIC of other PS for the isolates of both the varieties N. 
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dimidiatum and N. dimidiatum var. hyalinum (see Table 5). Higher 
concentrations of MB, TBO or NMBN than S137 were necessary to kill 
ungerminated and germinated arthroconidia of the dematiaceous isolates (see 
Figs. 2 and S3). Additionally, it should be taken into account that, despite the 
higher activity of S137 compared with the other PS, the light source employed 
was optimal (i.e. coinciding with the longer-wavelength monomer peak) for TBO 
and NMBN but not for S137 or MB in terms of output wavelength 
(supplementary Fig. S2) [37]. The higher efficacy of APDT with S137 compared 
with the other phenothiazinium PS, including MB, was previously observed 
against microconidia of the dermatophytes T. rubrum and T. mentagrophytes 
[40]; the plant-pathogenic fungi Colletotrichum acutatum, C. gloeosporioides 
[53], Fusarium oxysporum, F. moniliforme and F. solani [44]; the saprophyte 
Aspegillus nidulans [41], and also against planktonic cells of several species of 
Candida [37]. The ability of the PS to bind to microbial cells and to produce 
singlet oxygen is important to the efficiency of the APDT. Although MB, NMBN, 
TBO and S137 do not differ much in the production of singlet oxygen, they differ 
markedly in their ability to bind to plasma membranes [68]. Both MB and TBO 
display log Poil/water < 0 which indicate a low lipophilicity. While NMBN and S137 
exhibit a higher lipophilic profile (log Poil/water > 0) [68-70]. The more lipophilic 
nature of these PS molecules determines their capacity to bind to cell 
membranes and is critical to define the extent of photoinduced membrane 
damage and consequently the efficiency of cell killing [70,44]. We evaluated the 
effect of the APDT with the four phenothiazinium PS on arthroconidia plasma 
membranes by evaluating changes in membrane permeability and peroxidation 
of the lipids. The propidium iodide (PI) staining-based assay is widely used to 
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evaluate the membrane integrity [54] and also has been considered a good 
marker for cell death associated with membrane alterations in fungi [71]. PI is a 
membrane-impermeable fluorescent dye that only penetrates cells with 
damaged plasma membranes. Treatments with MB, NMBN and TBO at 200 µM 
in the dark increased the membrane permeability of N. dimidiatum 
arthroconidia, and treatment with S137 at 10 µM had an even stronger effect, 
causing the staining of 100% of the arthroconidia of the three isolates (see Fig. 
4). Interestingly, despite the disturbance of the membrane that increased cell 
permeability to PI, most of the arthroconidia were still viable (see Fig. 4), which 
clearly indicates that the permeability to PI is not always a good marker for cell 
death in fungi. APDT with MB, NMBN, TBO and S137 increased the plasma 
membrane permeability of arthroconidia of N. dimidiatum and N. dimiditum var. 
hyalinum isolates, causing the PI staining of approximately 100% of the 
arthroconidia. 
 Polyunsaturated lipids are easily oxidized by reactive oxygen species 
resulting in a chain of reactions that has malondialdehyde as a major product 
[72]. APDT with S137 or NMBN but not with MB or TBO caused the 
peroxidation of arthroconidial lipids and consequently malondialdehyde 
production (see Fig. 5). Membrane damage efficiency of photodynamic 
treatment with phenothiazinium PS such as MB, TBO, 1,9-dimethyl methylene 
blue (DMMB) and S137 was previously studied using artificial liposomes [68]. 
The membrane damage efficiency followed the order S137 > DMMB > MB > 
TBO. Only the PS that had higher membrane/solution partition (S137 and 
NMMB) could permeabilize the lipid bilayer and cause membrane leakage and 
lipid oxidation. Moreover, only S137 altered the membrane structure. To some 
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extent, the present study confirmed these findings in living cells. In a recent 
study performed with microconidia of three Fusarium species we reported that 
APDT with the same phenothiazinium PS used in the present study damages 
the microconidial membrane but only with NMBN and S137 caused the 
peroxidation of the membrane lipids. Thus, despite the great difference between 
the two types of propagules (arthroconidia and microconidia), the effects of 
APDT on the membranes were similar and seem to be common to the different 
types of conidia. 
 
5. Conclusion 
The pigmented variety N. dimidiatum differs from the hyaline variety in 
other loci than the ones involved in the pigment biosynthesis, and the two 
varieties can be differentiated by multilocus sequence typing. The arthroconidia 
of the hyaline variety are more susceptible to antifungal drugs as well to APDT 
with phenothiazinium photosensitizers. APDT with the four PS damages the 
plasma membrane of arthroconidia of both varieties increasing its permeability 
to PI but only NMBN and S137 caused peroxidation of the membrane lipids. 
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Figure legends: 
 
Fig. 1. UPGMA dendrogram showing the genetic relationship among the 24 N. 
dimidiatum,6 N. dimidiatum var. hyalinum isolates and ATCC strains. The 
percentages of replicate dendrograms in which the associated taxa clustered 
together in the bootstrap test (1000 replicates) are shown next to the branches. 
The tree is drawn to scale, with branch lengths in the same units as those of the 
evolutionary distances used to infer the phylogenetic tree. LMC, laboratório de 
micologia clínica; ATCC 38907, N. dimidiatum var. hyalinum; ATCC 22190, N. 
dimidiatum. 
 
Fig. 2. N. dimidiatum and N. dimidiatum var. hyalinum colony color. A, C 
and E are the front of the colony; B, D and F are the back of the colony. The 
isolates were grown on potato desxtrose agar (PDA) media culture at 28ºC for 6 
days. 
 
Fig. 3. Arthroconidia survival fraction of N. dimidiatum and N. dimidiatum var. 
hyalinum after APDT with MB (A), TBO (B), NMBN (C) and S137 (D). 
Arthroconidia were incubated with the PS for 30 min in the dark and exposed to 
fluences of 0 (dark controls), 5, 10 and 20 J cm-2. Error bars are standard 
deviation of three independent experiments. 
 
Fig. 4. Plasma membrane permeability of N. dimidiatum and N. dimidiatum var. 
hyalinum after APDT with MB, TBO, NMBN and S137. Arthroconidia stained 
36 
 
with propidium iodide (PI) (gray columns) and survival fraction (white squares). 
Error bars are standard deviation of three independent experiments. 
 
Fig. 5: Peroxidation of arthroconidia lipids of Neoscytalidium dimidiatum and N. 
dimidiatum var. hyalinum after APDT with MB, TBO, NMBN, and S137. Gray 
columns show the in situ generation of malondialdehyde (a marker for lipid 
peroxidation) and white squares show the arthroconidia survival fraction. Error 
bars are standard deviation of three independent experiments. 
 
Fig. S1. Chemical structures of the photosensitisers used in the study. 
Methylene blue (MB), new methylene blue (NMBN), toluidine blue O (TBO), and 
the new pentacyclic phenothiazinium photosensitizer S137. 
 
Fig. S2. Visible absorption spectra for the photosensitisers (10 μM) employed in 
the study and LED96 output. MB, methylene blue; NMBN, new methylene blue; 
TBO, toluidine blue O and S137, new pentacyclic phenothiazinium 
photosensitizer. 
 
Figure S3: Four-hour germinated arthroconidia survival fraction of N. 
dimidiatum and N. dimidiatum var. hyalinum  after APDT with MB (A), TBO (B), 
NMBN (C) and S137 (D). Arthroconidia were germinated in potato dextrose 
broth at 28ºC for 4 h. After, they were incubated with the PS for 30 min in the 
dark and exposed to fluences of 0 (dark controls) and 10 J cm-2. Error bars are 
standard deviation of three independent experiments. 
